BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11368554)

  • 21. Mass Spectrometric Quantitation of
    Li Y; Hecht SS
    Chem Res Toxicol; 2022 Sep; 35(9):1579-1588. PubMed ID: 36006857
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.
    Yuan JM; Knezevich AD; Wang R; Gao YT; Hecht SS; Stepanov I
    Carcinogenesis; 2011 Sep; 32(9):1366-71. PubMed ID: 21734256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue.
    Murphy SE; Heiblum R
    Carcinogenesis; 1990 Sep; 11(9):1663-6. PubMed ID: 2205411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumorigenic activity of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (iso-NNAL) and N'-nitrosonornicotine (NNN) on topical application to Sencar mice.
    LaVoie EJ; Prokopczyk G; Rigotty J; Czech A; Rivenson A; Adams JD
    Cancer Lett; 1987 Nov; 37(3):277-83. PubMed ID: 3677059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
    Chen G; Luo S; Kozlovich S; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters.
    Hoffmann D; Castonguay A; Rivenson A; Hecht SS
    Cancer Res; 1981 Jun; 41(6):2386-93. PubMed ID: 7237437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a rapid method for the simultaneous separation and determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its N- and O-glucuronides in human urine by liquid chromatography-tandem mass spectrometry.
    Yao L; Zheng S; Guan Y; Yang J; Liu B; Wang W; Zhu X
    Anal Chim Acta; 2013 Jul; 788():61-7. PubMed ID: 23845482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users.
    Stepanov I; Carmella SG; Han S; Pinto A; Strasser AA; Lerman C; Hecht SS
    Nicotine Tob Res; 2009 Jan; 11(1):99-105. PubMed ID: 19246447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats.
    Tyroller S; Zwickenpflug W; Thalheim C; Richter E
    Toxicology; 2005 Nov; 215(3):245-53. PubMed ID: 16118032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Zimmerman CL; Wu Z; Upadhyaya P; Hecht SS
    Carcinogenesis; 2004 Jul; 25(7):1237-42. PubMed ID: 14988218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of NADP(H) analogs of tobacco-specific nitrosamines in rat liver and pancreatic microsomes.
    Peterson LA; Ng DK; Stearns RA; Hecht SS
    Chem Res Toxicol; 1994; 7(5):599-608. PubMed ID: 7841337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined analysis of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users.
    Kotandeniya D; Carmella SG; Pillsbury ME; Hecht SS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Dec; 1007():121-6. PubMed ID: 26595795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.
    Carmella SG; Ming X; Olvera N; Brookmeyer C; Yoder A; Hecht SS
    Chem Res Toxicol; 2013 Aug; 26(8):1209-17. PubMed ID: 23837805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.
    Hecht SS; Carmella SG; Ye M; Le KA; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 2002 Jan; 62(1):129-34. PubMed ID: 11782369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk.
    Chung CJ; Lee HL; Yang HY; Lin P; Pu YS; Shiue HS; Su CT; Hsueh YM
    Sci Total Environ; 2011 Apr; 409(9):1638-42. PubMed ID: 21334728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
    Carmella SG; Ye M; Upadhyaya P; Hecht SS
    Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Brown B; Avalos J; Lee C; Doolittle D
    Mutat Res; 2001 Jul; 494(1-2):21-9. PubMed ID: 11423342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine.
    Carmella SG; Hecht SS
    Cancer Res; 1987 May; 47(10):2626-30. PubMed ID: 3567895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites.
    Hecht SS; Trushin N; Reid-Quinn CA; Burak ES; Jones AB; Southers JL; Gombar CT; Carmella SG; Anderson LM; Rice JM
    Carcinogenesis; 1993 Feb; 14(2):229-36. PubMed ID: 8435864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.